year 10, Issue 2 (May - June 2016)
Iran J Med Microbiol 2016, 10(2): 1-15 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Azadi D, Shojaei H. The role of the laboratory in the diagnosis of tuberculosis. Iran J Med Microbiol 2016; 10 (2) :1-15
URL: http://ijmm.ir/article-1-477-en.html
URL: http://ijmm.ir/article-1-477-en.html
1- Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
2- Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran ,hasanshojaei@msn.com
2- Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran ,
Abstract: (13103 Views)
Tuberculosis is one of the most important infectious diseases during the history of humans’ life, various societies always have been trying to control and struggle against this disease. Tuberculosis could be controlled by Koch's discovery of the tubercle bacillus as etiologic agent and the discovery of Bacillus Calmette–Guérin (BCG) vaccine all around the world. In fact, it had been assumed Tuberculosis could ultimately be eradicated, however any possible global control of tuberculosis will be destroyed in the near future because of the existence of tolerant strains, the worldwide distribution of the disease, as well as the emergence of the AIDS epidemic. The fact that one-third of the world's population is infected with Tuberculosis which can consider as a reservoir of infection. This issue has become even more complicated now since non-tuberculous mycobacteria (NTM) is indistinguishable than tuberculous mycobacteria because they are environmental organisms which present in all places and cause lung diseases and tuberculosis. Therefore, the laboratories diagnosis of tuberculosis (TB Laboratories) play a key role in diagnosing, monitoring and control of tuberculosis by providing prompt and reliable laboratory results, which can be the guidance clinical for control of tuberculosis. The aim of this research is a review of some scientific works (achievements) in relation to the quality and performance of TB Laboratories. As the researchers in the field of tuberculosis laboratories believe that increasing the capacity of laboratories using trained staff, implementation of quality control of equipment and procedures, can enhance the quality and accuracy of laboratory results. Generally, by creating a System National Administration for diagnostic laboratories, TB can be more effectively controlled.
Type of Study: Review Article |
Subject:
Medical Bacteriology
Received: 2015/09/10 | Accepted: 2016/02/25 | ePublished: 2016/07/14
Received: 2015/09/10 | Accepted: 2016/02/25 | ePublished: 2016/07/14
References
1. Daniel TM. The history of tuberculosis. Respir Med 2006 Nov, 30; 100(11):1862-70. [Article]
2. Razi AM. Stories and anecdotes disease. 2nd ed. Tehran, Uniersity of Tehran, 1356.
3. Azizi M H. History of TB in the world and Iran. Iran Med His 1389, 2(3): 11-36 [Article]
4. World Health Organization. Diagnostic and treatment delay in tuberculosis. 2006. ww.emro.who.int/dsaf/ dsa710. pdf/ Accessed May 2009. [Article]
5. Metanat M, Sharifi-Mood B, Alavi-Naini R, Aminianfar M. The epidemiology of tuberculosis in recent years: Reviewing the status in south-eastern Iran. ZJRMS 2012; 13 (9):1-7 [Article]
6. Steere AC, Corrales J, von Graevenitz A. A cluster of Mycobacterium gordonae isolates from bronchoscopy specimens. Am Rev Respir Dis 1979 Jul;120(1):214-6. [PubMed]
7. Stine TM, Harris AA, Levin S, Rivera N & Kaplan R L. A pseudo-epidemic due to atypical Mycobacteria in a hospital water supply. JAMA 1987 Aug 14;258(6):809-11. [Article]
8. Genus mycobacterium- Bacterial nomenclature up-to-date 2015-08-3. Available from http://www.dsmz.de/bactnom/nam3637.htm
9. Hartmans S, de Bont JA, Stackebrandt E. The Genus Mycobacterium--Nonmedical. InThe Prokaryotes. Springer New York; 2006. p. 889-918. [Article]
10. Chang C T, Wang L Y, Liao C Y, Huang S P. Identification of nontuberculous Mycobacteria existing in tap water by PCR-restriction fragment length polymorphism. Appl Environ Microbiol 2002 Jun 1;68(6):3159-61. [PubMed]
11. Dawson D J. Mycobacterial terminology. J Clin Microbiol 2000 Oct 1;38(10):3913-. [PubMed]
12. Vantrakis A, Tsintzoa A, Diamadopoulos, Dapapetropoulos M. Non tuberculosis Mycobacteria in hospital water supplie. Water Air Soil Pollut 1998 Jun 1;104(3-4):331-7. [Article]
13. Wallace R J, Brown B A, Griffith D E. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous Mycobacteria. Annu Rev Microbiol 1998 Oct;52(1):453-90. [PubMed]
14. Brunello F, Ligozzi M, Cristelli E, Bonora S, Tortoli E, Fontana R. Identification of 54 Mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp65 gene. J Clin Microbiol 2001 Aug 1;39(8):2799-806. [Article] [PubMed]
15. Huebner RE, Good RC, Takars JI. Current practices in mycobacteriology: results of a survey of state public health laboratories. J Clin Microbiol 1993 Apr 1;31(4):771-5. [PubMed]
16. Aziz, MA, Rysweska, K, Laszlo, A, Blanc, L. Strategic approach for the strengthening of laboratory services for tuberculosis control, 2006–2009 Geneva; WHO; 2006 (WHO/HTM/TB/2006.364). Available at: http://whqlibdoc.who.int/hq/2006/WHO_HTM_TB_2006.364_eng.pdf [Article]
17. The Stop TB Strategy. Geneva: WHO; 2006 (WHO/HTM/TB/2006.368). [Article]
18. Perkins MD, Roscigno G, Zumla A. Progress towards improved tuberculosis diagnostics for developing countries. Lancet 2006 Mar 18;367(9514):942-3. [PubMed]
19. Petti CA, Polage CR, Quinn TC, Ronald AR, Sande MA. Laboratory medicine in Africa: a barrier to effective health care. Clin Infect Dis 2006 Feb 1;42(3):377-82. [PubMed]
20. Centers for Disease Control and Prevention. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004. Morb Mortal Wkly Rep 2006 Mar 24;55(11):301. [PubMed]
21. Brown, Power EG, French GL. Evaluation of Three Commercial Detection Systems for Mycobacterium tuberculosis where clinical Diagnosis is Difficult. J Clin Pathol 1999 Mar 1;52(3):193-7. [PubMed]
22. Styblo K. The global aspects of tuberculosis and HIV infection. Bull Intl :::::union::::: Against Tuberc Lung Dis 1990 Mar;65(1):28-32. [PubMed]
23. Palomino JC. Nonconventional and new methods in the diagnosis of tuberculosis: Feasibility and applicability in the field. Eur Respir J 2005 Aug 1;26(2):339-50. [PubMed]
24. Munyati SS, Dhoba T, Makanza ED, Mungofa S, Wellington M, Mutsvangwa J, et al. Chronic cough in primary health care attendees, Harare, Zimbabwe: diagnosis and impact of HIV infection. Clin Infect Dis 2005 Jun 15;40(12):1818-27. [PubMed]
25. Aziz M, Ba F, Becx-Bleumink, Bretzel G, Humes R, Iademarco MF, et al. External quality assessment for AFB smear microscopy. WHO, CDC, APHL, KNCV, RIT, and IUATLD. Washington, DC. 2002.
26. Van Deun A, Portaels F. Limitations and requirements for quality control of sputum smear microscopy for acid-fast bacilli. Int J Tuberc Lung Dis 1998 Sep 1;2(9):756-65. [PubMed]
27. Mathew P, Kuo YH, Vazirani B, Eng RH, Weinstein MP. Are three sputum acid-fast bacillus smears necessary for discontinuing tuberculosis isolation? J Clin Microbiol. 2002 Sep 1;40(9):3482-4.. [PubMed]
28. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Anti-tuberculosis drug resistance in the world. Report No.3. Geneva: WHO; 2004 (WHO/CDS/TB/2004.343). Available at: http:// whqlibdoc.who.int/publications/2004/9241562854.pdf
29. Wayne l. Mycobaccterial speciation. In: Kubuca G, Wayne L, eds. the Mycobacteria: A Source book, Part A. New York, NY: Marcel Dekker. 1984. P.25-65.
30. Leao SC, Martin A, Mejia GI, Palomino JC, Robledo J, Telles MS, Portaels F. Practical handbook for the phenotypic and genotypic identification of mycobacteria. Vanden Broele, Brugge, Belgium. 2004. P.113-25. [Article]
31. M. Aziz, K. Ryszewska, L. Blanc, V. Vincent, H. Getahun, A. Wright, P. Nunn and M. Raviglione. Expanding culture and drug susceptibility testing capacity in tuberculosis diagnostic services: the new challenge. Int J Tuberc Lung Dis 2007 Mar 1;11(3):247-50. [Article]
32. National institute of health and clinical excellence. Guideline development methods: information for national collaborating centers and guideline developer. London: NICE, 2005. [Article]
33. Dinnes J, Deeks J, Kunst H, Gibson A, Cummins E, Waugh N,& Lalvani, A. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess: 2007. 11.3 [PubMed]
34. Shojaei H, Heidarieh P, Hashemi A, Feizabadi M M & Naser A D. Species identification of neglected nontuberculous mycobacteria in a developing country. Jpn J Infect Dis 2011 Jul 1;64(4):265-71. [PubMed]
35. Tortoli E, Rogasi PG, Fantoni E, Beltrami C, De Francisci A, Mariottini A. Infection due to a novel mycobacterium, mimicking multidrug‐resistant Mycobacterium tuberculosis. Clin Microbiol Infect 2010 Aug 1;16(8):1130-4. [PubMed]
36. Springer B, Stockman L, Teschner K, Roberts GD, Böttger EC. Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbio 1996 Feb 1;34(2):296-303. [PubMed]
37. Tortoli E, Bartoloni A, Böttger EC, Emler S, Garzelli C, Magliano E, Mantella A, Rastogi N, Rindi L, Scarparo C, Urbano P. Burden of unidentifiable mycobacteria in a reference laboratory. J Clin Microbio 2001 Nov 1;39(11):4058-65. [PubMed]
38. Shojaei H, Goodfellow M, Magee JG, Freeman R, Gould FK, Brignall CG. Mycobacterium novocastrense sp. nov., a rapidly growing photochromogenic mycobacterium. Int J Syst Evol Microbiol 1997 Oct 1;47(4):1205-7. [PubMed]
39. Azadi D, Dibaj R, Pourchangiz M, Daei-Naser A, Shojaei H. First report of isolation of Mycobacterium canariasense from hospital water supplies. Scand J Infect Dis 2014 Nov 1;46(11):792-6. [PubMed]
40. Sethi S, Sharma S, Sharma SK, Meharwal SK, Jindal SK, Sharma M. Drug susceptibility of Mycobacterium tuberculosis to primary antitubercular drugs by nitrate reductase assay. Indian J Med Res 2004 Nov 1;120(5):468. [PubMed]
41. Shah NS, Wright A, Bai GH, Barrera L, Boulahbal F, Martín-Casabona N, et al. Extensively drug resistance in tuberculosis (XDR-TB): global survey of supranational reference laboratories for Mycobacterium tuberculosis with resistance to second-line drugs. Int J Tuberc Lung Dis 2005;9(Suppl 1):S77.
42. Sharma SK, Mohan A. HIV-TB co-infection: Epidemiology, diagnosis & management. Indian J Med Res 2005 Apr 1;121(4):550-67.
43. Jarand J, Levin A, Zhang L, Huitt G, Mitchell JD, Daley C.L. Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease. Clin Infect Dis 2011 Mar 1;52(5):565-71. [PubMed]
44. Canetti G, Froman S, Grosset J, Hauduroy P, Langerova M, Mahler HT, Meissner G, Mitchison DA, Sula L. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963;29(5):565. [PubMed]
45. Molavi A, Weinstein L. In vitro susceptibility of atypical mycobacteria to rifampin. Appl Microbiol 1971 Jul 1;22(1):23-5. [PubMed]
46. Stone MS, Wallace Jr RJ, Swenson JM, Thornsberry C, Christensen LA. Agar disk elution method for susceptibility testing of Mycobacterium marinum and Mycobacterium fortuitum complex to sulfonamides and antibiotics. Antimicrob Agents Chemother 1983 Oct 1;24(4):486-93. [PubMed]
47. Snider Jr DE, Good RC, Kilburn JO, Laskowski Jr LF, Lusk RH, Marr JJ, Reggiardo Z, Middlebrook G. Rapid drug-susceptibility testing of Mycobacterium tuberculosis. Am Rev Respir Dis 1981 Apr;123(4):402-6.
48. Wayne PA. CLSI, 2011. Susceptibility testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes; Approved Standard – Second Edition. CLSI document M24-A2. Clinical and Laboratory Standards Institute 2011.
49. Drobniewski F, Rusch-Gerdes S, Hoffner S. Antimicrobial susceptibility testing of Mycobacterium tuberculosis (EUCAST document E.DEF 8.1)—report of the Subcommittee on Antimicrobial Susceptibility Testing of Mycobacterium tuberculosis of the European Committee for Antimicrobial Susceptibility Test-ing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). Clin Microbiol Infect 2007 Dec 1;13(12):1144-56. [PubMed]
50. Ericsson HM, Sherris JC. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Path. et Microb. Scandinavica. 1971(Suppl. 217). [PubMed]
51. Swenson JM, Thornsberry C, Silcox VA. Rapidly growing mycobacteria: testing of susceptibility to 34 antimicrobial agents by broth microdilution. Antimicrob Agents Chemother 1982 Aug 1;22(2):186-92. [PubMed]
52. Fabry W, Schmid EN, Ansorg R. Comparison of the E test and a proportion dilution method for susceptibility testing of Mycobacterium avium complex. J Med Microbiol 1996 Mar 1;44(3):227-30. [PubMed]
53. feyzabadi MM, Bahreh mand AR, Heydarieh P, Shojaei H. Using multilocus enzyme electerophoresis to study the heterogenecity of clinical isolates of Mycobacterium kansasii. I J Med Mic. 2008; 1(4): 1-11. [Article]
54. Van Deun A, Portaels F. Limitations and requirements for quality control of sputum smear microscopy for acid-fast bacilli. Int J Tuberc Lung Dis 1998 Sep 1;2(9):756-65. [PubMed]
55. Smithwick R. Laboratory manual for acid-fast microscopy, 2nd ed. Atlanta: US Department of Health, Education, and Welfare; Center for Disease Control; 1976.
56. Addo KK, Dan-Dzide M, Yeboah-Manu D, Owusu-Darko K, Caulley P, Minamikawa M, et al. Improving the laboratory diagnosis of TB in Ghana: the impact of a quality assurance system. Int J Tuberc Lung Dis 2006 Jul 1;10(7):812-7. [PubMed]
57. Laszlo A, Rahman M, Espinal, M. Raviglione. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 2002 Sep 1;6(9):748-56. [PubMed]
58. Bennett DE, Courval JM, Onorato I, Agerton T, Gibson JD, Lambert L, McQuillan GM, Lewis B, Navin TR, Castro KG. Prevalence of tuberculosis infection in the United States population: the national health and nutrition examination survey, 1999–2000. Am. J Respi Crit Care Med 2008 Feb 1;177(3):348-55. [PubMed]
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright Policy
Iranian Journal of Medical Microbiology by Farname is licensed under CC BY-NC 4.0
